secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sigyn Therapeutics, Inc. (SIGY)
CIK:        0001642159
Form:       8-K
Filed at:   2024-01-31T23:59:59+00:00
Accession:  0001493152-24-004502
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Sigyn Therapeutics effects 1-for-40 reverse stock split; symbol gets 'D' suffix for 20 days
--------------------------------------------------------------------------------

- Reverse stock split effective January 30, 2024 at a 1-for-40 ratio.
- Ticker symbol changes to 'SIGYD' for 20 business days per FINRA rules.
- Standard symbol 'SIGY' will resume after the 20-business-day period.
- No change in the company's CUSIP or par value was disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1642159/000149315224004502/0001493152-24-004502-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1642159/000149315224004502/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-004502

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer